Treatment of Depression in Acute Coronary Syndromes with Selective Serotonin Reuptake Inhibitors

被引：0
|
作者：
Joost P. van Melle
Peter de Jonge
Maarten P. van den Berg
Harm J. Pot
Dirk J. van Veldhuisen
机构：
[1] University Medical Center Groningen,Department of Cardiology, Thoraxcenter
[2] University of Groningen,Department of Internal Medicine and Psychiatry
[3] University Medical Center Groningen,Department of Psychiatry
[4] University of Groningen,undefined
[5] University Medical Center Groningen,undefined
[6] University of Groningen,undefined
来源：
Drugs | 2006年 / 66卷
关键词：
Acute Coronary Syndrome; Heart Rate Variability; Fluoxetine; Paroxetine; Sertraline;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Depression in patients with acute coronary syndromes (ACS) is common and associated with impaired cardiovascular prognosis in terms of cardiac mortality and new cardiovascular events. It remains unclear whether antidepressant treatment may reverse these effects. In this review, the literature is evaluated on (i) the antidepressant efficacy of selective serotonin reuptake inhibitors (SSRIs) for depression in patients with ACS; (ii) the pleiomorphic effects of SSRIs that may be associated with cardiovascular prognosis; and (iii) the effects of SSRIs on cardiovascular prognosis.
引用
收藏
页码：2095 / 2107
页数：12
相关论文
共 50 条
  • [21] Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Parkinson's Disease: A Systematic Review and Meta-Analysis
    Gao, Renjie
    Zhao, Panpan
    Yan, Kai
    CLINICAL DRUG INVESTIGATION, 2024, 44 (07) : 459 - 469
  • [22] Combining selective serotonin reuptake inhibitors and cognitive behavioral therapy in youth with depression and anxiety
    Strawn, Jeffrey R.
    Mills, Jeffrey A.
    Suresh, Vikram
    Peris, Tara S.
    Walkup, John T.
    Croarkin, Paul E.
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 298 : 292 - 300
  • [23] Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: A systematic review and meta-analysis
    von Wolff, A.
    Hoelzel, L. P.
    Westphal, A.
    Haerter, M.
    Kriston, L.
    JOURNAL OF AFFECTIVE DISORDERS, 2013, 144 (1-2) : 7 - 15
  • [24] Selective Serotonin Reuptake Inhibitors for the Treatment of Irritable Bowel Syndrome
    Bundeff, Andrew W.
    Woodis, C. Brock
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (06) : 777 - 784
  • [25] Selective serotonin reuptake inhibitors in the treatment of social phobia: The emerging gold standard
    Van Ameringen M.
    Mancini C.
    Oakman J.M.
    Farvolden P.
    CNS Drugs, 1999, 11 (4) : 307 - 315
  • [26] Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents
    Leonard, HL
    March, J
    Rickler, KC
    Allen, AJ
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1997, 36 (06) : 725 - 736
  • [27] PHARMACOLOGICAL CHARACTERIZATION OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS)
    HYTTEL, J
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1994, 9 : 19 - 26
  • [28] Selective serotonin reuptake inhibitors for children and adolescents.
    Kastelic E.A.
    Labellarte M.J.
    Riddle M.A.
    Current Psychiatry Reports, 2000, 2 (2) : 117 - 123
  • [29] Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice
    Pires, JGP
    Bonikovski, V
    Futuro-Neto, HA
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2005, 38 (12) : 1867 - 1872
  • [30] Treatment of selective mutism: Focus on selective serotonin Reuptake inhibitors
    Kaakeh, Yaman
    Stumpf, Janice L.
    PHARMACOTHERAPY, 2008, 28 (02): : 214 - 224
12345